Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

Introduction Weight gain following antiretroviral therapy (ART) initiation is common, potentially predisposing some persons with HIV (PWH) to cardio‐metabolic disease. We assessed relationships between ART drug class and weight change among treatment‐naïve PWH initiating ART in the North American AI...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the International AIDS Society Vol. 23; no. 4; pp. e25484 - n/a
Main Authors:	Bourgi, Kassem, Jenkins, Cathy A, Rebeiro, Peter F, Palella, Frank, Moore, Richard D, Altoff, Keri N, Gill, John, Rabkin, Charles S, Gange, Stephen J, Horberg, Michael A, Margolick, Joseph, Li, Jun, Wong, Cherise, Willig, Amanda, Lima, Viviane D, Crane, Heidi, Thorne, Jennifer, Silverberg, Michael, Kirk, Gregory, Mathews, William C, Sterling, Timothy R, Lake, Jordan, Koethe, John R
Format:	Journal Article
Language:	English
Published:	Switzerland John Wiley & Sons, Inc 01.04.2020 John Wiley and Sons Inc
Subjects:	Acquired immune deficiency syndrome Adult Age AIDS Antiretroviral agents Antiretroviral drugs Body mass index Body weight Canada CD4 Lymphocyte Count Cohort Studies Collaboration Complications and side effects Drug resistance Drug therapy Female Heterocyclic Compounds, 3-Ring - adverse effects Highly active antiretroviral therapy HIV HIV Infections - complications HIV Infections - drug therapy HIV Integrase Inhibitors - adverse effects HIV Integrase Inhibitors - therapeutic use HIV patients HIV Protease Inhibitors - adverse effects HIV Protease Inhibitors - therapeutic use Human immunodeficiency virus Humans Integrase inhibitors Male metabolic Metabolic disorders Middle Aged North America obesity Observational studies Oxazines Piperazines Protease inhibitors Proteinase inhibitors Pyridones Quality control Reverse transcriptase inhibitors Reverse Transcriptase Inhibitors - adverse effects Reverse Transcriptase Inhibitors - therapeutic use Risk factors Sexually transmitted diseases Statistics STD United States Weight gain Weight Gain - drug effects Canada United States United States > US integrase inhibitors HIV North America obesity weight gain metabolic
ISSN:	1758-2652, 1758-2652
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!